&nbsp;

Asset 3.png

Sep 2019

Document

Asset 4.png

Sep 2019

Document

Asset 5.png

Sep 2019

Document

Asset 7.png

Sep 2019

Regimen

ALEM

Cancer Type:

Hematologic,

Lymphoma - T-cell,

Rare Diseases

Intent: Palliative

Drugs Used:

alemtuzumab (Compassionate)

Quick Link(s):

Regimen Monograph

Sep 2019

Regimen

GEMC

Cancer Type:

Hematologic,

Lymphoma - T-cell,

Rare Diseases

Intent: Palliative

Drugs Used:

gemcitabine

Quick Link(s):

Regimen Monograph

Sep 2019

Blog post

Guidelines ensure consistent high-quality care across the province

Dr. Leta Forbes, Medical OncologistProvincial Head, Systemic Treatment ProgramOntario Health (Cancer Care Ontario) Reactions to the injection of...

Sep 2019

Regimen

ATEZ(MNT)

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

Drugs Used:

atezolizumab,

atezolizumab (subcut)

Quick Link(s):

Regimen Monograph

Regimen

ATEZBEVA(MNT)

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

atezolizumab (Unfunded),

bevacizumab (Unfunded)

Quick Link(s):

Regimen Monograph

Regimen

AC-PACL(W)+PERT+TRAS

Cancer Type:

Breast

Intent: Curative, Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

DOXOrubicin,

cyclophosphamide,

PACLitaxel,

PERTuzumab (Unfunded),

trastuzumab